Immune cell phenotype and function in sepsis

Shock

Volumn 45, Issue 3, 2016, Pages 282-291

  Rimmelé, Thomas ^a   Payen, Didier ^b   Cantaluppi, Vincenzo ^c   Marshall, John ^d   Gomez, Hernando ^e   Gomez, Alonso ^f,g   Murray, Patrick ^h   Kellum, John A ^e  

^a UNIVERSITÉ LYON 1   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f Academia Colombiana de Medicina Critica (ACOMEC)   (Colombia)

^g Division of Critical Care Medicine   (Colombia)

^h UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Blood purification; flow cytometry; immune cells; inflammation; lymphocyte; monocyte; neutrophil; sepsis

Indexed keywords

CELL SURFACE MARKER; HLA DR ANTIGEN;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CONSENSUS DEVELOPMENT; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LEUKOCYTE; LEUKOCYTE FUNCTION; LYMPHOCYTOPENIA; MONOCYTE; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; REVIEW; SEPSIS; ANIMAL; CELLULAR IMMUNITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; IMMUNOSUPPRESSION; SEPSIS; T-LYMPHOCYTES;

EID: 84959161804     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000495     Document Type: Review

References (118)

1. Angus DC, Van Der Poll T. Severe sepsis, and septic shock. N Engl J Med 369(9): 840-851, 2013
2. Wiersinga WJ, Leopold SJ, Cranendonk DR, Van Der Poll T. Host innate immune responses to sepsis. Virulence 5(1): 36-44, 2014
3. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, et al. A network-based analysis of systemic inflammation in humans. Nature 437(7061): 1032-1037, 2005
4. Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med 20(4): 195-203, 2014
5. Kellum JA, Gómez H, Gómez A, Murray P, Ronco C, on behalf of the ADQI XIV Workgroup. Acute dialysis quality initiative (ADQI) XIV sepsis phenotypes, and targets for blood purification in sepsis: The Bogotá Consensus. Shock 45(3): 242-248, 2016
6. Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils, and monocytes. Blood 112(4): 935-945, 2008
7. Savill JS, Wyllie AH, Henson JE, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. JClin Invest 83(3): 865-875, 1989
8. Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, Borghans JA, Tesselaar K, Koenderman L. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 116(4): 625-627, 2010
9. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A 93(6): 2588-2592, 1996
10. de Kleijn S, Kox M, Sama IE, Pillay J, Van Diepen A, Huijnen MA, Van Der Hoeven JG, Ferwerda G, Hermans PW, Pickkers P. Transcriptome kinetics of circulating neutrophils during human experimental endotoxemia. PLoS One 7(6): e38255, 2012
11. Visser T, Pillay J, Pickkers P, Leenen LP, Koenderman L. Homology in systemic neutrophil response induced by human experimental endotoxemia, and by trauma. Shock 37(2): 145-151, 2012
12. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110(9): 3507-3512, 2013
13. Wong HR, Freishtat RJ, Monaco M, Odoms K, Shanley TP. Leukocyte subsetderived genomewide expression profiles in pediatric septic shock. Pediatr Crit Care Med 11(3): 349-355, 2010
14. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 37(3): 882-888, 2009
15. Nauseef WM, Borregaard N. Neutrophils at work. Nat Immunol 15(7): 602-611, 2014
16. Yipp BG, Kubes P. NETosis: how vital is it? Blood 122(16): 2784-2794, 2013
17. Marshall JC, Malam Z, Jia SH. Modulating neutrophil apoptosis. In. Novartis Foundation, editor. Sepsis: New Insights, New Therapies. Chichester, UK. Wiley, 2007, pp. 53-72
18. Ahmed NA, McGill S, Yee J, Hu F, Michel RP, Christou NV. Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response (sepsis). Crit Care Med 27(11): 2459-2468, 1999
19. Romaschin AD, Foster DM, Walker PM, Marshall JC. Let the cells speak: neutrophils as biologic markers of the inflammatory response. Sepsis 2(2): 119-125, 1998
20. Taneja R, Parodo J, Kapus A, Rotstein OD, Marshall JC. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential (DYM), and reduced caspase-9 activity. Crit Care Med 32(7): 1460-1469, 2004
21. Watson RW, Rotstein OD, Parodo J, Bitar R, Marshall JC. The interleukin-1 beta converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1b. J Immunol 161(2): 957-962, 1998
22. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, Marshall JC. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation, and clinical sepsis. J Clin Invest 113(9): 1318-1327, 2004
23. Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, Payen D. Monocytic HLA-DR expression in intensive care patients: interest for prognosis, and secondary infection prediction. Crit Care Med 37(10): 2746-2752, 2009
24. Venet F, Tissot S, Debard AL, Faudot C, Crampé C, Pachot A, Ayala A, Monneret G. Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity, and secondary septic shock. Crit Care Med 35(8): 1910-1917, 2007
25. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nature Med 3(6): 678-681, 1997
26. Venet F, Lukaszewicz AC, Payen D, Hotchkiss R, Monneret G. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol 25(4): 477-483, 2013
27. Vaki I, Kranidioti H, Karagianni V, Spyridaki A, Kotsaki A, Routsi C, Giamarellos-Bourboulis EJ. An early circulating factor in severe sepsis modulates apoptosis of monocytes, and lymphocytes. J Leukoc Biol 89(3): 343-349, 2011
28. Koffel R, Meshcheryakova A, Warszawska J, Hennig A, Wagner K, Jorgl A, Gubi D, Moser D, Hladik A, Hoffmann U, et al. Monocytic cell differentiation from band-stage neutrophils under inflammatory conditions via MKK6 activation. Blood 124(17): 2713-2724, 2014
29. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation, and cancer. J Immunol 182(8): 4499-4506, 2009
30. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3): 162-174, 2009
31. Sander LE, Sackett SD, Dierssen U, Beraza N, linke RP, Muller M, Blander JM, Tacke F, Trautwein C. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 207(7): 1453-1464, 2010
32. Derive M, Bouazza Y, Alauzet C, Gibot S. Myeloid-derived suppressor cells control microbial sepsis. Intensive Care Med 38(6): 1040-1049, 2012
33. Guerin E, Orabona M, Raquil MA, Giraudeau B, Bellier R, Gibot S, Bene MC, Lacombe F, Droin N, Solary E, et al. Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration. Crit Care Med 42(9): 2007-2018, 2014
34. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 23(4): 344-346, 2005
35. Dinauer MC. Disorders of neutrophil function: an overview. Methods Mol Biol 412: 489-504, 2007
36. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet 368(9530): 157-169, 2006
37. Hoesel LM, Neff TA, Neff SB, Younger JG, Olle EW, Gao H, Pianko MJ, Bernacki KD, Sarma JV, Ward PA. Harmful, and protective roles of neutrophils in sepsis. Shock 24(1): 40-47, 2005
38. Jimenez MF, Watson RW, Parodo J, Evans D, Foster D, Steinberg M, Rotstein OD, Marshall JC. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg 132(12): 1263-1270, 1997
39. Jia SH, Parodo J, Charbonney E, Tsang JL, Jia SY, Rotstein OD, Kapus A, Marshall JC. Activated neutrophils induce epithelial cell apoptosis through oxidant-dependent tyrosine dephosphorylation of caspase-8. Am J Pathol 184(4): 1030-1040, 2014
40. Wang JF, Li JB, Zhao YJ, Yi WJ, Bian JJ, Wan XJ, Zhu KM, Deng XM. Upregulation of programmed cell death 1 ligand 1 on neutrophils may be involved in sepsis-induced immunosuppression: an animal study, and a prospective casecontrol study. Anesthesiology 122(4): 852-863, 2015
41. Wenzel RP, Edmond MB. Septic shock-evaluating another failed treatment. N Engl J Med 366(22): 2122-2124, 2012
42. Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, Kellum JA. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 41(1): 3-11, 2014
43. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder, and a new therapeutic approach. Lancet Infect Dis 13(3): 260-268, 2013
44. Zahorec R. Ratio of neutrophil to lymphocyte counts: rapid, and simple parameter of systemic inflammation, and stress in critically ill. Bratisl Lek Listy 102(1): 5-14, 2001
45. Tschaikowsky K, Hedwig-Geissing M, Schiele A, Bremer F, Schywalsky M, Schuttler J. Coincidence of pro-and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic, and postoperative patients. Crit Care Med 30(5): 1015-1023, 2002
46. Holub M, Kluckova Z, Helcl M, Prihodov J, Rokyta R, Beran O. Lymphocyte subset numbers depend on the bacterial origin of sepsis. Clin Microbiol Infect 9(3): 202-211, 2003
47. Kelly-Scumpia KM, Scumpia PO, Weinstein JS, Delano MJ, Cuenca AG, Nacionales DC, Wynn JL, Lee PY, Kumagai Y, Efron PA, et al. B cells enhance early innate immune responses during bacterial sepsis. J Exp Med 208(8): 1673-1682, 2011
48. Monserrat J, de Pablo R, Diaz-Martin D, Rodriguez-Zapata M, De La Hera A, Prieto A, Alvarez-Mon M. Early alterations of B cells in patients with septic shock. Crit Care 17(3): R105, 2013
49. Andaluz-Ojeda D, Iglesias V, Bobillo F, Almansa R, Rico L, Gandia F, Loma AM, Nieto C, Diego R, Ramos E, et al. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care 15(5): R243, 2011
50. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13(12): 862-874, 2013
51. Schneider RP, Christou NV, Meakins JL, Nohr C. Humoral immunity in surgical patients with, and without trauma. Arch Surg 126(2): 143-148, 1991
52. Rode HN, Christou NV, Gordon J, Meakins JL, MacLean LD. Anergy in surgical patients: is the failure at the afferent or the efferent limb? Surg Forum 30: 41-43, 1979
53. Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH, Pachot A, Brooks TL, Deych E, Shannon WD, et al. Reactivation of multiple viruses in patients with sepsis. PLoS One 9(2): e98819, 2014
54. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J, Lepape A. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 31(7): 2068-2071, 2003
55. Chang KC, Burnham CA, Compton SM, Rasche DP, Mazuski RJ, McDonough JS, Unsinger J, Korman AJ, Green JM, Hotchkiss RS. Blockade of the negative co-stimulatory molecules PD-1, and CTLA-4 improves survival in primary, and secondary fungal sepsis. Crit Care 17(3): R85, 2013
56. Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Bohe J, Lepape A, Ayala A, Monneret G. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 35(4): 678-686, 2009
57. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, et al. Immunosuppression in patients who die of sepsis, and multiple organ failure. JAMA 306(23): 2594-2605, 2011
58. Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42(5): 383-391, 2014
59. Hotchkiss RS, Karl IE. The pathophysiology, and treatment of sepsis. N Engl J Med 348(2): 138-150, 2003
60. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27(7): 1230-1251, 1999
61. Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation, and quiescence. Immunity 38(4): 633-643, 2013
62. Losser MR, Damoisel C, Payen D. Bench-to-bedside review: glucose, and stress conditions in the intensive care unit. Crit Care 14(4): 231, 2010
63. Losser MR, Bernard C, Beaudeux JL, Pison C, Payen D. Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol 83(5): 1566-1574, 1997
64. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 354(5): 449-461, 2006
65. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 345(19): 1359-1367, 2001
66. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science 335(6071): 936-941, 2012
67. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447(7147): 972-978, 2007
68. Hoeboer SH, Groeneveld AB. Changes in circulating procalcitonin versus Creactive protein in predicting evolution of infectious disease in febrile, critically ill patients. PLoS One 8(6): e65564, 2013
69. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults, and after surgery or trauma: a systematic review, and meta-analysis. Crit Care Med 34(7): 1996-2003, 2006
70. Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, Fumagalli R, Mauri T, Isgrò S, Fanizza C, et al. Presepsin (soluble CD14 subtype), and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care 18(1): R6, 2014
71. Luz Fiusa MM, Costa-Lima C, de Souza GR, Vigorito AC, Penteado Aranha FJ, Lorand-Metze I, Annichino-Bizzacchi JM, de Souza CA, De Paula EV. A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia. Crit Care 17(4): R169, 2013
72. Lorente L, Martín MM, Varo N, Borreguero-León JM, Solé-Violán J, Blanquer J, Labarta L, Díaz C, Jiménez A, Pastor E, et al. Association between serum soluble CD40 ligand levels, and mortality in patients with severe sepsis. Crit Care 15(2): R97, 2011
73. Huttunen R, Syrjänen J, Vuento R, Laine J, Hurme M, Aittoniemi J. Apoptosis markers soluble Fas (sFas), Fas Ligand (FasL), and sFas/FasL ratio in patients with bacteremia: a prospective cohort study. J Infect 64(3): 276-281, 2012
74. Andaluz-Ojeda D, Iglesias V, Bobillo F, Almansa R, Rico L, Gandía F, Loma AM, Nieto C, Diego R, Ramos E, et al. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care 15(5): R243, 2011
75. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Powell WS, Monneret G. Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol 177(9): 6540-6547, 2006
76. Duong S, Condotta SA, Rai D, Martin MD, Griffith TS, Badovinac VP. Polymicrobial sepsis alters antigen-dependent, and -independent memory CD8 T cell functions. J Immunol 192(8): 3618-3625, 2014
77. Patschan SA, Patschan D, Temme J, Korsten P, Wessels JT, Koziolek M, Henze E, Müller GA. Endothelial progenitor cells (EPC) in sepsis with acute renal dysfunction (ARD). Crit Care 15(2): R94, 2011
78. Trimmel H, Luschin U, Köhrer K, Anzur C, Vevera D, Spittler A. Clinical outcome of critically ill patients cannot be defined by cutoff values of monocyte human leukocyte antigen-DR expression. Shock 37(2): 140-144, 2012
79. Wu JF, Ma J, Chen J, Ou-Yang B, Chen MY, Li LF, Liu YJ, Lin AH, Guan XD. Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis. Crit Care 15(5): R220, 2011
80. Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, Misset B, Captain Study Group, Adib-Conquy M, Cavaillon JM. CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization, and reactive oxygen species production of human neutrophils is impaired in sepsis. J Immunol 192(5): 2449-2459, 2014
81. Dimoula A, Pradier O, Kassengera Z, Dalcomune D, Turkan H, Vincent JL. Serial determinations of neutrophil CD64 expression for the diagnosis, and monitoring of sepsis in critically ill patients. Clin Infect Dis 58(6): 820-829, 2014
82. Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S, Robbins P, Ulbrandt N, Suzich J, Green J, et al. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care 18(1): R3, 2014
83. Forel JM, Chiche L, Thomas G, Mancini J, Farnarier C, Cognet C, Guervilly C, Daumas A, Vély F, Xéridat F, et al. Phenotype, and functions of natural killer cells in critically-ill septic patients. PLoS One 7(12): e50446, 2012
84. Kjaergaard AG, Nielsen JS, Tønnesen E, Krog J. Expression of NK cell, and monocyte receptors in critically ill patients potential biomarkers of sepsis. Scand J Immunol 81(4): 249-258, 2015
85. Brahmamdam P, Watanabe E, Unsinger J, Chang KC, Schierding W, Hoekzema AS, Zhou TT, McDonough JS, Holemon H, Heidel JD, et al. Targeted delivery of siRNA to cell death proteins in sepsis. Shock 32(2): 131-139, 2009
86. Payen D, Lukaszewicz AC, Belikova I, Faivre V, Gelin C, Russwurm S, Launay JM, Sevenet N. Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med 34(8): 1371-1376, 2008
87. Cajander S, Bäckman A, Tina E, Strålin K, Söderquist B, Källman J. Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis. Crit Care 17(5): R223, 2013
88. Payen D, Lukaszewicz AC, Legrand M, Gayat E, Faivre V, Megarbane B, Azoulay E, Fieux F, Charron D, Loiseau P, et al. A multicentre study of acute kidney injury in severe sepsis, and septic shock: association with inflammatory phenotype, and HLA genotype. PLoS One 7(6): e35838, 2012
89. Song Z, Song Y, Yin J, Shen Y, Yao C, Sun Z, Jiang J, Zhu D, Zhang Y, Shen Q, et al. Genetic variation in the TNF gene is associated with susceptibility to severe sepsis, but not with mortality. PLoS One 7(9): e46113, 2012
90. Loupy A, Lefaucheur C, Vernerey D, Chang J, Hidalgo LG, Beuscart T, Verine J, Aubert O, Dubleumortier S, Duong Van Huyen JP, et al. Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. J Am Soc Nephrol 25(10): 2267-2277, 2014
91. Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, Quintana C, Osorio JC, Wang Z, Zhao Y, et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation, and validation. PLoS Med 10(12): e1001577, 2013
92. Avriel A, ParyenteWiessman M, Almog Y, Perl Y, Novack V, Galante O, Klein M, Pencina MJ, Douvdevani A. Admission cell free DNA levels predict 28-day mortality in patients with severe sepsis in intensive care. PLoS One 9(6): e100514, 2014
93. Semmler A, Prost JC, Smulders Y, Smith D, Blom H, Bigler L, Linnebank M. Methylation metabolism in sepsis, and systemic inflammatory response syndrome. Scand J Clin Lab Invest 73(5): 368-372, 2013
94. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, Chandwani R, Marazzi I, Wilson P, Coste H, et al. Suppression of inflammation by a synthetic histone mimic. Nature 468(7327): 1119-1123, 2010
95. Tacke F, Roderburg C, Benz F, Cardenas DV, Luedde M, Hippe HJ, Frey N, Vucur M, Gautheron J, Koch A, et al. Levels of circulating miR-133a are elevated in sepsis, and predict mortality in critically ill patients. Crit Care Med 42(5): 1096-1104, 2014
96. Ma Y, Vilanova D, Atalar K, Delfour O, Edgeworth J, Ostermann M, Hernandez-Fuentes M, Razafimahatratra S, Michot B, Persing DH, et al. Genome-wide sequencing of cellular microRNAs identifies a combinatorial expression signature diagnostic of sepsis. PLoS One 8(10): e75918, 2013
97. Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie L. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational study. PLoS One 7(6): e38885, 2012
98. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78(9): 838-848, 2010
99. Azevedo LC, Janiszewski M, Pontieri V, Pedro Mde A, Bassi E, Tucci PJ, Laurindo FR. Platelet-derived exosomes from septic shock patients induce myocardial dysfunction. Crit Care 11(6): R120, 2007
100. Gambim MH, do Carmo Ade O, Marti L, Veríssimo-Filho S, Lopes LR, Janiszewski M. Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction. Crit Care 11(5): R107, 2007
101. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358(2): 111-124, 2008
102. Marti-Carvajal AJ, Sola I, Lathyris D, Cardona AF. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev 3: CD004388, 2012
103. Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmuller A, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, et al. Attenuation of sepsisrelated immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 29(7): 1423-1430, 2001
104. Gong D, Zhang P, Ji D, Chen Z, Li W, Li J, Li L, Liu Z. Improvement of immune dysfunction in patients with severe acute pancreatitis by high-volume hemofiltration: a preliminary report. Int J Artif Organs 33(1): 22-29, 2010
105. Ono S, Tsujimoto H, Matsumoto A, Ikuta S, Kinoshita M, Mochizuki H. Modulation of human leukocyte antigen-DR on monocytes, and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg 188(2): 150-156, 2004
106. Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized controlled trial. Intensive Care Med 41(6): 975-984, 2015
107. Kumagai T, Takeyama N, Yabuki T, Harada M, Miki Y, Kanou H, Inoue S, Nakagawa T, Noguchi H. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock. Shock 34(5): 461-466, 2010
108. Rimmelé T, Kaynar AM, McLaughlin JN, Bishop JV, Fedorchak MV, Chuasuwan A, Peng Z, Singbartl K, Frederick DR, Zhu L, et al. Leukocyte capture, and modulation of cell-mediated immunity during human sepsis: an ex vivo study. Crit Care 17(2): R59, 2013
109. Peng ZY, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal, and short-term survival in septic rats. Crit Care Med 36(5): 1573-1577, 2008
110. Peng ZY, Bishop JV, Wen XY, Elder MM, Zhou F, Chuasuwan A, Carter MJ, Devlin JE, Kaynar AM, Singbartl K, et al. Modulation of chemokine gradients by apheresis redirects leukocyte trafficking to different compartments during sepsis, studies in a rat model. Crit Care 18(4): R141, 2014
111. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 30(6): 1250-1255, 2002
112. Cantaluppi V, Weber V, Lauritano C, Figliolini F, Beltramo S, Biancone L, De Cal M, Cruz D, Ronco C, Segoloni GP, et al. Protective effect of resin adsorption on septic plasma-induced tubular injury. Crit Care 14(1): R4, 2010
113. Morgera S, Haase M, Rocktaschel J, Bohler T, von Heymann C, Vargas-Hein O, Krausch D, Zuckermann-Becker H, Muller JM, Kox WJ, et al. High permeability haemofiltration improves peripheral blood mononuclear cell proliferation in septic patients with acute renal failure. Nephrol Dial Transplant 18(12): 2570-2576, 2003
114. Morgera S, Haase M, Rocktaschel J, Bohler T, Vargas-Hein O, Melzer C, Krausch D, Kox WJ, Baumann G, Beck W, et al. Intermittent high-permeability hemofiltration modulates inflammatory response in septic patients with multiorgan failure. Nephron Clin Pract 94(3): c75-80, 2003
115. Leentjens J, Kox M, Koch RM, Preijers F, Joosten LA, Van Der Hoeven JG, Netea MG, Pickkers P. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med 186(9): 838-845, 2012
116. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180(7): 640-648, 2009
117. Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S, Robbins P, Ulbrandt N, Suzich J, Green J, et al. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care 18(1): R3, 2014
118. Venet F, Foray AP, Villars-Méchin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G. IL-7 restores lymphocyte functions in septic patients. J Immunol 189(10): 5073-5081, 2012